FIGURE 5
FROM:
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death
Ville-Petteri Mäkinen, Pasi Soininen, Carol Forsblom, Maija Parkkonen, Petri Ingman, Kimmo Kaski, Per-Henrik Groop & Mika Ala-Korpela for the FinnDiane Study Group
doi:10.1038/msb4100205
BACK TO ARTICLE
Validation of the biochemical accuracy of the 1H NMR data and neural network analysis. (A–I) Measurements of clinical markers by standard (non-NMR) biochemistry, visualized on the SOM of 1H NMR spectra. (E) Apolipoprotein B-100, (F) HDL3 cholesterol, (G) insulin dose, (H) glycemic control and (I) 24 h-urine albumin were included instead of those metabolites from Figure 4 that were estimated by 1H NMR.